ArticleSurgical endoscopy2026
Perioperative and oncologic outcomes of 1,000 consecutive single-port transaxillary robotic thyroidectomy (SP-TART).
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEvidence on single-port transaxillary robotic thyroidectomy (SP-TART) remains limited. We evaluated perioperative outcomes, early oncologic results, and complication-specific risk factors in a large consecutive SP-TART cohort.
methodsWe retrospectively reviewed 1,000 consecutive patients who underwent da Vinci SP-TART at a single institution between 2021 and 2025. Perioperative outcomes, postoperative complications, and clinicopathologic data were collected from medical records and final pathology reports. Hypoparathyroidism was classified as transient (≤ 12 months) or permanent (> 12 months), and recurrent laryngeal nerve (RLN) injury was confirmed by postoperative laryngoscopy. Logistic regression analyses were performed to identify factors associated with RLN injury and hypoparathyroidism.
resultsMean age was 40.9 ± 11.6 years, and 87.2% of patients were female. Less-than-total thyroidectomy was performed in 83.0%, total thyroidectomy in 8.9%, completion thyroidectomy in 0.4%, and modified radical neck dissection in 7.7%. Mean operative time was 79.1 ± 42.0 min. Final pathology was malignant in 85.1%, benign in 11.6%, and noninvasive follicular thyroid neoplasm with papillary-like nuclear features in 3.3%. Among malignant cases, papillary thyroid carcinoma accounted for 98.2%, and mean tumor size was 1.1 ± 0.9 cm. Major postoperative complications included transient and permanent hypoparathyroidism in 7.4 and 0.4%, respectively, and transient and permanent RLN injury in 4.1 and 0.2%, respectively. During a mean follow-up of 22.7 ± 13.3 months, recurrence occurred in 0.8%, with no disease-specific mortality. In the less-than-total cohort, larger tumor size and gross extrathyroidal extension were independently associated with RLN injury. In the total thyroidectomy/completion thyroidectomy/modified radical neck dissection cohort, no independent risk factor for hypoparathyroidism was identified.
conclusionsSP-TART demonstrated acceptable perioperative outcomes and low early recurrence during short-term follow-up in a large consecutive cohort predominantly composed of low-risk thyroid cancer patients. Surgical extent was closely associated with hypoparathyroidism, whereas RLN injury was more strongly related to tumor burden and local invasiveness.
Indexed as
Identifiers
42527738What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.